Maria Abdul Razak holds two issued patents on universal influenza virus-like particle vaccines and leads funded programs spanning avian influenza, SARS-CoV-2 and JEV. Develops cross-protective VLP platforms validated in chickens and mice for poultry and dual-use applications.
This innovator hasn't added publications yet. In the meantime, you might want to explore their patents, funding, and other profile details.
Immunogenicity and protective efficacy of nodavirus-like particles displaying the haemagglutinin genes of the highly pathogenic avian influenza virus strain H5Nx as a potential avian influenza vaccine for chickens
GCRF Networks in Vaccines Research and Development which was co-funded by the MRC and BBSRC, and was supported by the International Veterinary Vaccinology Network (IVVN), UK.
•
$80,000
•
2020 - 2022
Universal avian influenza vaccine based on recombinant virus-like particles
Issued
•
2024
A 2-In-1 universal influenza A vaccine based on recombinant virus-like particle.